Cumberland Partners LTD Novo Nordisk A S Transaction History

Cumberland Partners LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $576,859 - $690,623	-4,701 Reduced 3.05%	149,653 $21.4 Million
Q1 2024 May 09, 2024	BUY	$102.11 - $135.92 $6.21 Million - $8.27 Million	60,840 Added 65.06%	154,354 $19.8 Million
Q4 2023 Feb 01, 2024	SELL	$87.78 - $105.45 $21,945 - $26,362	-250 Reduced 0.27%	93,514 $9.67 Million
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $4.33 Million - $9.49 Million	47,582 Added 103.03%	93,764 $8.53 Million
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $7.2 Million - $7.97 Million	46,182 New	46,182 $7.47 Million

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Cumberland Partners LTD with notifications on news.